当前位置:首页 - 行情中心 - 信邦制药(002390) - 财务分析 - 现金流量表

信邦制药

(002390)

  

流通市值:52.82亿  总市值:53.26亿
流通股本:19.28亿   总股本:19.44亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,665,545,644.991,196,706,849.045,867,264,378.244,392,910,428.84
  收到其他与经营活动有关的现金91,262,149.4467,159,652.95122,520,087.7996,340,560.94
  经营活动现金流入小计2,756,807,794.431,263,866,501.995,989,784,466.034,489,250,989.78
  购买商品、接受劳务支付的现金1,762,211,966.54898,223,279.373,984,561,846.823,053,053,427.03
  支付给职工以及为职工支付的现金365,317,368.12200,210,605.37698,424,171.01544,680,196.39
  支付的各项税费110,665,776.0454,360,511.18243,520,403.14161,804,358.28
  支付其他与经营活动有关的现金117,323,223.1265,560,754.29330,747,422.55268,130,705.72
  经营活动现金流出小计2,355,518,333.821,218,355,150.215,257,253,843.524,027,668,687.42
  经营活动产生的现金流量净额401,289,460.6145,511,351.78732,530,622.51461,582,302.36
二、投资活动产生的现金流量:
  收回投资收到的现金612,115,816.54300,000,000220,743,323.4410,000,000
  取得投资收益收到的现金16,261,642.741,034,803.2719,832,583.06341,843.03
  处置固定资产、无形资产和其他长期资产收回的现金净额450,550382,6506,330,361.31788,991.7
  投资活动现金流入小计628,828,009.28301,417,453.27246,906,267.8111,130,834.73
  购建固定资产、无形资产和其他长期资产支付的现金18,873,585.712,042,391.0285,420,518.8766,335,825.59
  投资支付的现金600,000,000300,000,000200,000,000-
  投资活动现金流出小计618,873,585.71302,042,391.02285,420,518.8766,335,825.59
  投资活动产生的现金流量净额9,954,423.57-624,937.75-38,514,251.06-55,204,990.86
三、筹资活动产生的现金流量:
  取得借款收到的现金250,000,000118,000,000440,000,000382,000,000
  收到其他与筹资活动有关的现金74,358,466.2974,358,466.2982,795,072.5682,795,072.56
  筹资活动现金流入小计324,358,466.29192,358,466.29522,795,072.56464,795,072.56
  偿还债务支付的现金255,100,000118,000,000766,200,000613,200,000
  分配股利、利润或偿付利息支付的现金121,120,155.723,797,792.21260,501,338.54219,858,190.48
  其中:子公司支付给少数股东的股利、利润1,521,000-129,678,950102,534,950
  支付其他与筹资活动有关的现金46,066,923.3658,955,535.3183,306,876.2449,660,193.01
  筹资活动现金流出小计422,287,079.08180,753,327.521,110,008,214.78882,718,383.49
  筹资活动产生的现金流量净额-97,928,612.7911,605,138.77-587,213,142.22-417,923,310.93
四、汇率变动对现金及现金等价物的影响-2,093.14-1,328.773,141.57-1,859.81
五、现金及现金等价物净增加额313,313,178.2556,490,224.03106,806,370.8-11,547,859.24
  加:期初现金及现金等价物余额1,039,526,611.641,039,526,611.64932,720,240.84932,720,240.84
  期末现金及现金等价物余额1,352,839,789.891,096,016,835.671,039,526,611.64921,172,381.6
补充资料:
  净利润136,123,428.32-191,795,599.53-
  资产减值准备7,110,646.32-112,443,211.54-
  固定资产和投资性房地产折旧88,954,019.62-182,450,207.32-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧88,954,019.62-182,450,207.32-
  无形资产摊销7,378,564.32-14,814,843.02-
  长期待摊费用摊销6,395,336.74-14,317,244.69-
  处置固定资产、无形资产和其他长期资产的损失524,452.91-3,481,951.16-
  固定资产报废损失1,112,908.34-2,525,190.36-
  财务费用6,335,901.93-22,451,423.54-
  投资损失-18,116,460.74--19,740,275.61-
  递延所得税-8,476,620--28,811,956.39-
  其中:递延所得税资产减少-8,417,410.47--28,400,536.61-
    递延所得税负债增加-59,209.53--411,419.78-
  存货的减少157,051,707.22-147,627,246.85-
  经营性应收项目的减少231,553,218.19-288,636,052.61-
  经营性应付项目的增加-216,835,053.12--204,411,362.91-
  不涉及现金收支的投资和筹资活动金额其他项目5,120,066.85-744,056.24-
  现金的期末余额1,352,839,789.89-1,039,526,611.64-
  减:现金的期初余额1,039,526,611.64-932,720,240.84-
  现金及现金等价物的净增加额313,313,178.25-106,806,370.8-
公告日期2026-08-282026-04-292026-04-212025-10-29
审计意见(境内)标准无保留意见
TOP↑